Reply To: Too Premature to Deny the Potential of Thrombomodulin-Alfa in Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine - United States
doi 10.1164/rccm.202002-0398le
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Thoracic Society

Related search

Too Premature to Deny the Potential of Thrombomodulin-Alfa in Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2020English

To Authors Reply: Invasive Mechanical Ventilation in Patients With Idiopathic Pulmonary Fibrosis or Idiopathic Non-Specific Interstitial Pneumonia

Internal Medicine
Internal MedicineMedicine
2011English

Imaging: How to Recognise Idiopathic Pulmonary Fibrosis

European Respiratory Review
PulmonaryRespiratory Medicine
2014English

Investigational Approaches to Therapies for Idiopathic Pulmonary Fibrosis

Expert Opinion on Investigational Drugs
MedicinePharmacology
2010English

Idiopathic Pulmonary Fibrosis

Pulmonologiya
PulmonaryRespiratory Medicine
2015English

Idiopathic Pulmonary Fibrosis

2020English

The Pathogenesis of Idiopathic Pulmonary Fibrosis

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2010English

Pharmacological Treatment of Idiopathic Pulmonary Fibrosis: From the Past to the Future

European Respiratory Review
PulmonaryRespiratory Medicine
2013English

Epigenomics of Idiopathic Pulmonary Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy